Is white-coat hypertension innocent or detrimental?

Blood Pressure Monitoring

Volumn 4, Issue 5, 1999, Pages 241-247

  Mansoor, George A ^a   White, William B ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NONE

Author keywords

Ambulatory blood pressure; Office blood pressure; Office hypertension; White coat hypertension

Indexed keywords

ADULT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; WHITE COAT HYPERTENSION;

EID: 0033495640     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199910000-00007     Document Type: Review

References (55)

1. 1 Pickering TG. A review of national guidelines on the clinical use of ambulatory blood pressure monitoring. Blood Press Monit 1996; 1:151-156.
2. 2 Joint National Committee on Prevention, Detection, Evaluation and Treatment of high Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of high Blood Pressure. Arch Intern Med 1997; 157:2413-2446. The major document providing guidelines on the epidemiology, diagnosis and treatment of hypertension in the USA. The intention is to use evidence-based guidelines as far as possible.
3. 3 Grin JM, McCabe EJ, White WB. Management of hypertension after ambulatory blood pressure monitoring. Ann Intern Med 1993; 118:833-837.
4. 4 Mansoor GA. Clinical use of ambulatory blood pressure monitoring in a Veteran's Medical Center. Blood Press Monit 1997; 2:217-221.
5. 5 Gosse P, Bougaleb M, Egloff P, Lemetayer P, Clemety J. Clinical significance of white-coat hypertension. J Hypertens 1994; 12 (suppl 8):S43-S47.
6. 6 Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209-215.
7. 7 Pickering TG. Ambulatory monitoring and blood pressure variability. London: Science Press; 1991.
8. 8 Mancia G, Frattola A, Ulian L, Santueciu C, Parati G. Blood Pressures other than the one in the clinic. Blood Press 1997; 6 (suppl 2):81-85. A review of the relative utilities of office, exercise, home, and ambulatory blood pressure measurements. The authors suggest that current evidence indicates that ambulatory blood pressure is superior to office blood pressure, because it provides better correlations to target-organ damage and regression of left ventricular hypertrophy
9. 9 Pieper C, Warren K, Pickering TG. A comparison of ambulatory blood pressure and heart rate at home and work on work and non-work days. J Hypertens 1993; 11:177-183.
10. 10 Enstrom I, Pennert K. Does it matter whether ambulatory blood pressure is recorded during a work day or a non-work day? J Hypertens 1996; 14:565-569.
11. 11 O'Brien E, Staessen J. Normotension and hypertension as a defined by 24-hour ambulatory blood pressure monitoring. Blood Press 1995; 4:266-282.
12. 12 Staessen JA, Bieniaszewski L, O'Brien ET, Fagard R. What is normal blood pressure in ambulatory monitoring? Nephrol Dial Transplant 1996; 11:241-245.
13. 13 Manning G, Rushton L, Millar-Craig MW. Twenty-four hour ambulatory blood pressure: a sample from a normal British population. J Hum Hypertens 1998; 12:123-127.
14. 14 Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.
15. 15 Verdecchia P, Schillaci F, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of normal ambulatory blood pressure. Hypertension 1992; 20:555-562. A clear analysis of the potent effect of the cutoff blood pressure used in the diagnosis of white-coat hypertension. The safe definition of white-coat hypertension should be done using conservative cutoffs of blood pressure.
16. 16 Pearce KA, Evans GW, Summerson J, Rao S. Comparison of ambulatory blood pressure monitoring and repeated office measurements in primary care. J Fam Pract 1997; 45:426-433.
17. 17 Fogari R, Corradi L, Zoppi A, Lusardi P, Poletti L. Repeated office blood pressure controls reduce the prevalence of while-coat hypertension and detect a group of white-coat normotensive patients. Blood Press Monit 1996; 1:51-54. The importance of multiple office visits to diagnose hypertension is stressed. Likewise, in the diagnosis of white-coat hypertension, multiple office visits should be used.
18. 18 Siegel WC, Blumenthal JA, Divine GW. Physiological, psychological, and behavioral factors and white coat hypertension. Hypertension 1990; 16:140-146.
19. 19 Cardillo C, De Felice F, Campia U, Folli G. Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993; 21:836-844.
20. 20 Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Blum MJ. The white-coat hypertension response: prevalence and predictors. J Gen Intern Med 1989; 4:226-231.
21. 21 Ruddy MC, Bialy GB, Malka ES, Lacy CR, Kostis JB. The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension. J Hypertens 1988; 6 (suppl 6):S412-S415.
22. 22 Nakao M, Shimosawa T, Nomura S, Kuboki T, Fujita T, Muarata K. Mental arithmetic is a useful diagnostic evaluation in white-coat hypertension. Am J Hypertens 1998; 11:41-45.
23. 23 Donner-Branzhoff N, Chan Y, Szalai JP, Hilditch J. Is the clinic-home blood pressure difference associated with psychological distress? A primary care-based study. J Hypertens 1997; 15:585-590.
24. 24 Carels RA, Sherwood A, Blumenthal JA. High anxiety and white-coat hypertension. JAMA 1998; 279:197-198.
25. 25 Perloff D, Sokolow M, Cowan RM. The prognostic value of ambulatory blood pressure. JAMA 1983, 249:2792-2798.
26. 26 Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989; 7 (suppl 3):S3-S10.
27. 27 Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure; an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801. The main large study examining the prognosis of conservatively defined white-coat hypertension. Although it has been criticized for its design, its results reassure us that white-coat hypertensives probably have a low short-term cardiovascular risk.
28. 28 Mann S, Millar Craig MW, Raftery EB. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens [A] 1985; 7:279-281.
29. 29 Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364.
30. 30 Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension. A prospective study. Hypertension 1998; 31:712-718. Ambulatory blood pressure was superior at stratifying subjects in a group of subjects with refractory hypertension into risk categories. Higher ambulatory blood pressure predicted a worse prognosis for subjects with ambulatory diastolic blood pressures > 100 mmHg who were being administered triple drug therapy.
31. 31 Staessen JA, Byttebier G, Buntinx F, Cells H, O'Brien, Fagard R, for the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized, controlled trial. JAMA 1997; 278:1065-1072. A trial comparing office versus ambulatory blood pressure for guiding therapy of hypertension. Subjects whose treatment was guided by ambulatory blood pressure were eventually administered fewer medications and about 25% of them were able to discontinue drug therapy without incurring a short-term increase in left ventricular mass.
32. 32 Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini L, Salvatore L, et al. Whito-coat hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995; 16:692-697.
33. 33 Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory blood pressure. Hypertension 1990; 16:692-699.
34. 34 White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure determines cardiac function in patients with hypertension. JAMA 1989; 26:873-877.
35. 35 Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JR. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996, 348:654-657.
36. 36 Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
37. 37 Hoegholm A, Kristensen KS, Bang LE, Nielsen JW, Nielsen WB, Madson NH. Left ventricular mass and geometry in patients with established hypertension and white-coat hypertension. Am J Hypertens 1993, 6:282-286.
38. 38 Rizzo V, Cicconetti P, Bianchi A, Lorido A, Morelli S, Vetta F, et al. While-coat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens 1996; 10:293-298.
39. 39 Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90:2291-2298.
40. 40 Kuwajima I, Suzuki Y, Fujisawa A, Koramoto K. Is white-coat hypertension innocent? Hypertension 1993; 22:826-831.
41. 41 Soma J, Wideroe TE, Dahl K, Rossvoll O, Skjaerpe T. Left ventricular systolic and diastolic function assessed with two-dimensional and Doppler echocardiography in 'white-coat' hypertension. J Am Coll Cardiol 1996; 28:190-196.
42. 42 Palatini P, Penzo M, Canali C, Dorigatti F, Pessina A. Interactive action of the white-coat effect and the blood pressure levels on the cardiovascular complications in hypertension. Am J Med 1997; 103:208-216.
43. 43 Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens 1995, 13:1707-1711.
44. 44 Ferrara LA, Guida L, Pasanisi F, Celentano A, Palmieri V, Ianuzzi R, et al. Isolated office hypertension and end-organ damage. J Hypertens 1997; 15:979-985.
45. 45 Pose-Reino A, Gonzalez-Juanatey JR, Pastor C, Mendez I, Estevez JC, Alvarez D, et al. Clinical implications of the white-coat hypertension. Blood Press 1996; 5:264-273.
46. 46 Gosse P, Promax H, Durandet P, Clementy J. White coat hypertension; no harm for the heart. Hypertension 1993; 22:766-770.
47. 47 Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white-coat hypertension, and normotension. Hypertension 1994; 24:101-105.
48. 48 Palatini P, Mormino P, Santonastaso M, Mos L, Follo MD, Zanata G, et al. on behalf of the HARVEST investigators. Target-organ damage in stage I hypertensive subjects with white-coat hypertension and sustained hypertension. Hypertension 1998, 31:57-63. A large study of untreated subjects with mild hypertension in which white-coat hypertensives were found to have higher left ventricular masses than those of normotensives but lower masses than those of sustained hypertensives. These findings appeared independent from the cutoff criteria for white-coat hypertension used.
49. 49 White WB. Hypertensive target-organ involvement and 24-hour ambulatory BP measurement. In Waeber B, O'Brien E, O'Malley K, Brunner HR (editors): Twenty-four hour ambulatory blood pressure monitoring in clinical practice. New York: Raven Press; 1994. pp. 47-60.
50. 50 White WB. Ambulatory blood pressure and target organ involvement in hypertension. Clin Invest Med 1990; 14:224-230.
51. 51 Polonia JJ, Santos AR, Gama GM, Basto F, Bettencourt PM, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients. Blood Press Monit 1997; 2:289-295.
52. 52 White WB, Daragjati C, Mansoor GA, McCabe EJ. The management and follow up of patients with white-coat hypertension. Blood Press Monit 1996; 1 (suppl 2):S33-S36. One of the few follow-up studies of white-coat hypertensives including a normotensive group as a control. Similar proportions of patients in the two groups progressed to sustained hypertension over the follow-up period.
53. 53 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, et al. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit 1996; 1:217-222.
54. 54 Bidlingmeyer I, Burnier M, Bidlingemeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehyportensive state? J Hypertens 1996; 14:327-332.
55. 55 Zawadzka A, Bird R, Casadei B, Conway J. Audit of ambulatory blood pressure monitoring in the diagnosis and management of hypertension in practice. J Hum Hypertens 1998; 12:249-252.